- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in Oceania Countries, November 2012 (p5)
Talk to Robyn
(866) 682 9815
Search inside this page
Publication dates
Publishers
- Global Data (156)
- Global Markets Direct (77)
- Business Monitor International (13)
- GBI Research (4)
- Global Research & Data Services (8)
-
- ICD Research (17)
- Ibisworld (6)
- Mintel (14)
- Euromonitor International (31)
- Datamonitor (23)
- Timely Data Resources Inc. (17)
- VacZine Analytics Group Of Assay Advantage Ltd (9)
- Life Science Analytics (LSA) (8)
- MarketLine (8)
- World Market Intelligence Ltd (8)
- Frost & Sullivan (7)
- Espicom Business Intelligence (6)
- SCRIP Insights (6)
- Obainfo (3)
- ABMRG (3)
- Business Review (3)
- Global Industry Analyst (3)
- Koncept Analytics (3)
- Leatherhead Food Research (3)
- Daedal Research (2)
- Ken Research Private (2)
- Arrowhead (1)
- Bioseeker (1)
- CCM International Limited (1)
- Canadean Ltd (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Firstword Pharma (1)
- RNCOS (1)
- Strategic Defence Intelligence (SDI) (1)
- The Economist Intelligence Unit (1)
- Timetric (1)
All regions
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in Oceania Countries, November 2012 (p5)
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
121-150 of about 400 reports
Orencia (Rheumatoid Arthritis) Forecast and Market Analysis
- $ 3 495
- Company report
- November 2012
- by Global Data
Orencia (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Orencia (Rheumatoid Arthritis) Forecast and Market Analysis. The ...
- Industries : Pathology
- Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom, India
Actemra (Rheumatoid Arthritis) Forecast and Market Analysis
- $ 3 495
- Company report
- November 2012
- by Global Data
Actemra (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Actemra (Rheumatoid Arthritis) Forecast and Market Analysis. The ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, Japan, India, China, World, United States, Australia, Europe, United Kingdom
Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis
- $ 3 495
- Company report
- November 2012
- by Global Data
Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis. The ...
- Industries : Pathology
- Countries : United States, Spain, Italy, France, Germany, Japan, India, World, Australia, Europe, United Kingdom
FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis
- $ 3 495
- Industry report
- November 2012
- by Global Data
FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, FluBlok (Seasonal Influenza Vaccines) Forecast and Market ...
- Industries : Drug and Medication
- Countries : United States, World, Australia, Spain, Italy, France, Germany, Japan
Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis
- $ 3 495
- Industry report
- November 2012
- by Global Data
Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis. ...
- Industries : Pathology
- Countries : Germany, United States, Spain, Italy, France, Japan, World, Australia, Europe, United Kingdom, India
Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
- $ 125
- Company report
- November 2012
- by ICD Research
Synopsis ICD Research's "Apotex, Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains ...
- Industries : Generic Drug
- Countries : Canada, Czech Republic, New Zealand, Australia, Netherlands, Mexico, Poland, Belgium, World, Europe, Oceania, North America, United Kingdom
Biogen Idec Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
- $ 125
- Company report
- November 2012
- by ICD Research
Synopsis ICD Research's "Biogen Idec Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains ...
- Industries : Pathology
- Countries : United States, Australia, Canada, Japan, World
ImmusanT, Inc. - Product Pipeline Analysis
- $ 750
- Company report
- November 2012
- by Global Data
Summary ImmusanT, Inc. (ImmusanT) is a biotechnology company. It focuses on the development of treatment, and diagnostic and monitoring tools for managing patients suffering from celiac disease. Celiac ...
- Industries : Pathology
- Countries : United States, Australia
Pathology: Pacific Edge Limited (PEB)
- $ 750
- Company report
- November 2012
- by Global Data
This report is a source for data, analysis and actionable intelligence on the Pacific Edge Limited portfolio of new product development . The report provides detailed analysis on each pipeline product ...
- Industries : Pathology
- Countries : New Zealand, United States, Singapore
Limacorporate S.p.a. - Product Pipeline Analysis
- $ 750
- Company report
- November 2012
- by Global Data
Summary Limacorporate S.p.a. (Lima) is a medical device company. It designs and manufactures orthopaedics and traumatology products to the respective industries. The company's major products include artificial ...
- Industries : Drug Discovery and Development
- Countries : San Marino, Italy, Australia, United States, World
Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2012
- $ 2 000
- Company report
- November 2012
- by Global Markets Direct
Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2012', provides an overview of the ...
- Industries : Drug and Medication
- Countries : World, Australia
Drug Discovery and Development in Australia: Biotron Limited - Product Pipeline Review - H2 2011
- $ 1 500
- Company report
- November 2012
- by Global Markets Direct
The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced ...
- Industries : Therapy
- Countries : Australia, World
BioDiem Ltd - Product Pipeline Review - 2012
- $ 1 500
- Company report
- November 2012
- by Global Markets Direct
BioDiem Ltd - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?BioDiem Ltd - Product Pipeline Review - 2012? provides data on the BioDiem Ltd's research and development ...
- Industries : Drug and Medication
- Countries : United States, Australia, World, India
Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012
- $ 2 500
- Company report
- November 2012
- by Global Markets Direct
Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012', provides an overview of the ...
- Industries : Drug and Medication
- Countries : Australia, World
Kawasaki Disease - Pipeline Review, H2 2012
- $ 2 000
- Company report
- November 2012
- by Global Markets Direct
Kawasaki Disease - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Kawasaki Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Pathology
- Countries : World, Australia
Bionomics Limited - Product Pipeline Review - 2012
- $ 1 500
- Company report
- November 2012
- by Global Markets Direct
Bionomics Limited - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Bionomics Limited - Product Pipeline Review - 2012? provides data on the Bionomics Limited's ...
- Industries : Drug Discovery and Development
- Countries : United States, Australia, World
Pharmaceuticals Market Overview in Australia
- $ 350
- Industry report
- November 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Pharmaceutical
- Countries : Australia
Pharmaceuticals Market Overview in New Zealand
- $ 350
- Industry report
- November 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Pharmaceutical
- Countries : New Zealand
HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth
- $ 3 500
- Industry report
- November 2012
- by GBI Research
HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth Summary GBI Research, a leading business intelligence ...
- Industries : Therapy
- Countries : World, Japan, Europe, India, China, Australia, United States
Ego Pharmaceuticals Pty Ltd SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : Australia, Singapore, World
QRxPharma Limited (Symbol:QRX) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug Discovery and Development
- Countries : Australia, United States
Probiomics Ltd. (Symbol:PCC) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : Australia
Progen Pharmaceuticals Limited (Symbol:PGL) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : Australia
Biota Holdings Limited (Symbol:BTA) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : Australia
Disease and Therapy Review: Crohn%s Disease
- $ 995
- Industry report
- November 2012
- by Timely Data Resources Inc.
Abstract The Crohn's Disease Disease and Therapy Review provides an overview of the condition, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview ...
- Industries : Therapy
- Countries : South Korea, World, Italy, Canada, Japan, Europe, North America, Australia, Singapore, United States, United Kingdom, Spain, France, Germany, China, Asia
Disease and Therapy Review: Lung Cancer
- $ 995
- Industry report
- November 2012
- by Timely Data Resources Inc.
Abstract The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information ...
- Industries : Therapy
- Countries : World, Russian Federation, Europe, Philippines, Argentina, South Africa, Brazil, Mexico, Canada, Spain, Poland, Italy, Greece, France, Germany, Thailand, Japan, India, China, Egypt, Asia, Africa, United States, United Kingdom, South America, Australia, Sweden, South Korea, North America
Cerep SA (ALCER) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Cerep SA (Cerep) focuses on offering in vitro and in vivo solutions. The solutions allow early discovery of encouraging drug candidates and terminating compounds likely to fail in development. ...
- Industries : Drug Discovery and Development
- Countries : Canada, France, Australia
Cerebos Pacific Limited (Symbol:C20) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
Cerebos Pacific Limited, (Cerebos) is a Singapore based company. The company is mainly engaged in the manufacturing and marketing of food products and health supplements. The company's product line includes ...
- Industries : Vitamin and Supplement
- Countries : Singapore, New Zealand, Australia, Asia
Blackmores Limited (Symbol:BKL) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : Australia, South Korea, New Zealand, Singapore
Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review
- $ 250
- Company report
- November 2012
- by Global Data
Summary Solagran Limited (Solagran), formerly known as Solagran International is a biotechnology company. It undertakes research and development, and commercialization of natural and biologically active ...
- Industries : Pathology
- Countries : Australia, Netherlands, World
» Download Public Reports
About 1 500 reports
Company Report: Hair Loss in The United States and Australia for Year 2013
- Company report
- March 2013
- 19 pages
... Commercial and licensing deals. In addition, we view diabetic nephropathy program and future partnerships in molecular diagnostics as an upside to our current target price, with strong ip around midkine ...
The Australian Drug And Medication Industry
March 2013The Australian Medicine Industry Brief
April 2013» Read our Company Profiles
12 CompaniesGlaxoSmithKline P.L.C.
United StatesSanofi-Aventis Senegal
SenegalManagement Strategies
United StatesAbbott Laboratories
United StatesJohnson and Johnson
United StatesReportlinker.com © Copyright 2013. All rights reserved.
